ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats

Morgan Stanley Upgrades ResMed (RMD) to Overweight

July 31, 2015 10:01 AM EDT

Morgan Stanley upgraded ResMed (NYSE: RMD) from Equalweight to Overweight.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $56.12 yesterday.

... More

ResMed (RMD) PT Bumped to $66 at Needham & Company Posts Q4

July 31, 2015 8:02 AM EDT

Needham & Company analyst Mike Matson reiterated a Buy rating and raised his price target on ResMed (NYSE: RMD) to $66.00 (from $65.00) following solid Q4 results driven by flow generator product cycle.

Matson commented, "RMD's revenue and EPS beat consensus as its revenue... More

Deutsche Bank Downgrades ResMed (RMD) to Sell

July 31, 2015 7:32 AM EDT

Deutsche Bank downgraded ResMed (NYSE: RMD) from Hold to Sell with a price target of $53.00 (from $61.00). The change follows Q4 results. Analyst David Low noted strong sales offset by GM weakness.

"After the incredible success of ResMeds AirSense range we are wary FY16... More